From the ENSAT-CANCER related PMT Clinical Trial support by the Melbourne eResearch Group.

G. Eisenhofer, A. Prejbisz, M. Peitzsch, C. Pamporaki, J. Masjkur, N. Rogowski-Lehmann K. Langton, E. Tsourdi, M. Pęczkowska, S. Fliedner, T. Deutschbein, F. Megerle, H. Timmers, R.O. Sinnott, F. Beuschlein, M. Fassnacht, A. Januszewicz J. Lenders MD, Biochemical Diagnosis of Pheochromocytoma and Paraganglioma: Plasma versus Urinary O-Methylated Catecholamine Metabolites in Patients at High and Low Risk of Disease, Journal of Clinical Chemistry, July 2018.